C.B. Srikant

CB Srikant

Coimbatore B. Srikant, Ph.D.

Professor, Department of Medicine
Endocrine Division, McGill University Health Centre
Fraser Laboratories, H5.21, Royal Victoria Hospital
687, Pine Avenue West, Montreal, QC H3A 1A1

Tel: 514-934-1934 ext. 35359

coimbatore.srikant [at] mcgill.ca

Biographical Sketch

Academic Degree: Ph. D. 1973, University of Madras, Madras, India
Post-Doctoral Training: 1974-1978 (Dr. Roger Unger), Department of Internal Medicine, University of Texas Health Science Center and V.A. Hospital, Dallas, TX, U.S.A.
Assistant Professor, 1982 Department of Medicine, McGill University
Associate Professor, 1990, Department of Medicine, McGill University
Professor, 2000- , Department of Medicine, McGill University


Research in cancer biology and diabetes, cellular signaling, flow cytometry

Research or Clinical Activities

The focus of my research is the elucidation of the mechanisms of cytoprtoective effects of growth factors and somatostatin. Our findings have provided novel insights into the receptor subtype-specific antiproliferative action of somatostatin. It exerts cytotoxic action causing apoptosis in estrogen responsive breast cancer cells and in pituitary tumor cells. Its action is SHP-1-dependent and leads to induction of p53, Bax, an acidic endonuclease and decrease in intracellular pH. These actions are uniquely mediated by a single human somatostatin receptor subtype (hSSTR3). We showed also that somatostatin promotes hypophosphorylion of Rb leading to G1 cell cycle arrest via other hSSTRs (hSSTR5>2>4>1). These findings imply the potential therapeutic utility of SST analogs in oncology, but with varied outcome depending on the relative abundance of the SSTR, and the mediators of apoptosis and cell cycle in a given tumor. More recently, our work has centered on the Reg genes that promote pancreatic b-cell survival, growth and function. We have found that induced expression of murine Reg2 in mouse insulinoma cells induces the basal expression of the ER chaperone protein GRP78 and inhibits the detrimental unfolded protein response leading to apoptosis induced by glucolipotoxicity and chemical inducers of ER stress. These findings point to the beneficial effect of induced expression of Reg in protecting islet cells against glucolipotoxic stress encountered in type 2 diabetes and obesity.

Selected Recent Publications

Thangaraju, M., Sharma, K., Liu, D., Shen, S-H. and Srikant, C.B. Interdependent regulation of intracellular acidification and SHP-1 in apoptosis. Cancer Research 59: 1649-1654, 1999.

Tourian, L , Zhao, H. and Srikant, C.B. p38alpha, but not p38beta, inhibits the phosphorylation of c-flips and its presence in disc to potentiate fas-mediated caspase-8 activation and type I signaling whereas both isoforms promote type II signaling. J. Cell Sci. 117: 6459-6471, 2004.

L Liu, JL Liu, CB Srikant. Reg2 protects mouse insulinoma cells from streptozotocin-induced apoptosis by preventing mitochondrial disruption and caspase-3 activation. Growth Factors 2010 28: 370-378.

Li, B, Lu, Y, Srikant, C.B. and Liu, J-L.. Intestinal adaptation and Reg gene expression caused by anti-diabetic duodenal-jejunal bypass surgery in Zucker fatty rats. Am J Physiol-GI Liver 304: G635-645, 2013.

Liu L, Chowdhury, S, Liu J-L and Srikant C.B. Attenuation of unfolded protein response and apoptosis by mReg2-induced GRP78 in mouse insulinoma cells. FEBS Lett. ms in review 2013.

PubMed Publications – C. Srikant